Schonfeld Strategic Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-115,250	Closed	-$1.8M	–	2656
2025 Q4	$1.8M	Buy	+115,250	New	+$1.65M	0.01%	915
2025 Q2	–	Sell	-79,464	Closed	-$1.18M	–	2530
2025 Q1	$1.18M	Buy	79,464 +14,113	+22%	+$198K	0.01%	1216
2024 Q4	$865K	Sell	65,351 -17,851	-21%	-$245K	0.01%	1179
2024 Q3	$1.18M	Sell	83,202 -6,198	-7%	-$87.9K	0.01%	1107
2024 Q2	$1.16M	Buy	+89,400	New	+$1.18M	0.01%	1135
2023 Q4	–	Sell	-136,100	Closed	-$2.11M	–	2196
2023 Q3	$2.11M	Buy	+136,100	New	+$2.11M	0.02%	814
2022 Q3	–	Sell	-52,700	Closed	-$740K	–	3155
2022 Q2	$740K	Buy	52,700 +29,100	+123%	+$415K	0.01%	1158
2022 Q1	$338K	Sell	23,600 -9,600	-29%	-$141K	﹤0.01%	1616
2021 Q4	$452K	Buy	+33,200	New	+$466K	﹤0.01%	1315
2021 Q3	–	Sell	-173,500	Closed	-$2.92M	–	2458
2021 Q2	$2.92M	Buy	173,500 +122,800	+242%	+$2.09M	0.03%	600
2021 Q1	$926K	Buy	+50,700	New	+$912K	0.01%	931
2020 Q3	–	Sell	-188,764	Closed	-$3.38M	–	1645
2020 Q2	$3.38M	Buy	+188,764	New	+$3.39M	0.09%	289
2019 Q3	–	Sell	-54,900	Closed	-$971K	–	1229
2019 Q2	$971K	Hold	54,900	–	–	0.03%	449
2019 Q1	$1.12M	Buy	+54,900	New	+$1.1M	0.04%	475